Table 2 Frequency of acquired HIV drug resistance mutations

M184V/I

119 (56.4%)

K103k/N/S/E

96 (52.2%)

V82A/I/M/C

18 (29.0%)

T215Y/N/S/F/I

45 (21.3%)

P225H

31 (16.1%)

M46I

17 (27.4%)

K219E/Q/R

40 (19.0%)

M230L

17 (9.2%)

L54V/L

11 (17.7%)

V75M/C/A

35 (16.6%)

Y181C/S

17 (9.2%)

L90M

10 (16.1%)

M41L

26 (12.3%)

V108i

15 (8.15%)

L50V/L

9 (14.5%)

D67N/G/Q

23 (10.9%)

K101Ekqr

13 (7.1%)

V32i

6 (9.7%)

K70R/T/I/E/Q

21 (10.0%)

E138A/G

13 (7.1%)

L76v

2 (3.2%)

T69S/N/P/I

11 (5.2%)

V179tf

11 (6.0%)

I84v

2 (3.2%)

K65R/E/I/N/G

11 (5.2%)

K238tn

8 (4.3%)

F77L/C

5 (2.4%)

A98g

8 (4.3%)

L74V/I

5 (2.4%)

V106mia

5 (2.7%)

Y115F

1 (0.5%)

H221Y

3 (1.6%)

L100v

2 (1.1%)

P236l

1 (0.5%)

N348i

1 (0.5%)